- Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumabC Galera
Allergy and Respiratory Diseases Unit, Hopital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France
J Investig Allergol Clin Immunol 19:225-9. 2009..AntiIgE has provided a treatment option for patients with severe IgE-mediated allergic disease that is difficult to treat. This case suggests that omalizumab may be able to prevent anaphylaxis during immunotherapy...